Comparison

MIA PaCa-2 cells

Item no. C0018002
Manufacturer Addexbio
Amount One Frozen vial
Category
Type Tumour Cells
Specific against Human (Homo sapiens)
Dry ice Yes
Citations 1.Hussein, D. and Mo, H. d-delta-Tocotrienol-mediated suppression of the proliferation of human PANC-1, MIA PaCa-2, and BxPC-3 pancreatic carcinoma cells. Pancreas, 38: e124-136, 2009.
2.Reigan, P., Colucci, M. A., Siegel, D., Chilloux, A., Moody, C. J., and Ross, D. Development of indolequinone mechanism-based inhibitors of NAD(P)H:quinone oxidoreductase 1 (NQO1): NQO1 inhibition and growth inhibitory activity in human pancreatic MIA PaCa-2 cancer cells. Biochemistry, 46: 5941-5950, 2007.
3.Kato, S., Shirato, K., Imaizumi, K., Toyota, H., Mizuguchi, J., Odawara, M., Che, X. F., Akiyama, S., Abe, A., and Tomoda, A. Anticancer effects of phenoxazine derivatives combined with tumor necrosis factor-related apoptosis-inducing ligand on pancreatic cancer cell lines, KLM-1 and MIA-PaCa-2. Oncol Rep, 15: 843-848, 2006.
4.Fogli, S., Nieri, P., Chicca, A., Adinolfi, B., Mariotti, V., Iacopetti, P., Breschi, M. C., and Pellegrini, S. Cannabinoid derivatives induce cell death in pancreatic MIA PaCa-2 cells via a receptor-independent mechanism. FEBS Lett, 580: 1733-1739, 2006.
5.Roomi, M. W., Ivanov, V., Kalinovsky, T., Niedzwiecki, A., and Rath, M. Antitumor effect of a combination of lysine, proline, arginine, ascorbic acid, and green tea extract on pancreatic cancer cell line MIA PaCa-2. Int J Gastrointest Cancer, 35: 97-102, 2005.
6.Hashimoto, K., Farrow, B. J., and Evers, B. M. Activation and role of MAP kinases in 15d-PGJ2-induced apoptosis in the human pancreatic cancer cell line MIA PaCa-2. Pancreas, 28: 153-159, 2004.
ECLASS 10.1 32160890
ECLASS 11.0 32160890
UNSPSC 41106509
Available
Description
Disease:
Pancreatic carcinoma
Origin:
An established cell line from an undifferentiated human pancreatic carcinoma
Species:
Homo sapiens
Tissue:
Pancreas
Morphology:
Epithelial
Properties:
Adherent, single cells and loosely attached clusters
Cytogenic data:
Tumorigenic; Modal no. 61; hypotriploid
Patient:
Male, Caucasian, 65 yrs of age
Medium:
AddexBio-formulated DMEM (C0003-01) + 10% FBS
Subculture:
1:3 to 1:6 using 0.25% trypsin or trypsin/EDTA, 5% CO2; 37C
Freezing Medium:
Complete culture medium supplemented with 5% (v/v) DMSO
Biosafety Level: I
Sterility:
Bacteria: Negative
Yeast: Negative
Mycoplasma: Negative
Pathogens:
HIV: Negative
Hepatitis B: Negative
Hepatitis C: Negative
Protein Expression: human colony stimulating factor, subclass I (CSF-I); plasminogen activator
Isoenzymes: G6PD, B
DNA Profile (STR): Amelogenin: X CSF1PO: 10 D13S317: 12, 13 D16S539: 10, 13 D5S818: 12, 13 D7S820: 12, 13 THO1: 9, 10 TPOX: 9 vWA: 15 Mutations in MIA PaCa-2 Cells
Related cells by Organ: AR-42J cells
BxPc-3 cells
Capan-1 cells
MIA PaCa-2 cells
E3LZ10.7 cells
A10.7 cells
INS-1 cells
MIN-6 cells
Storage condition
LN2
Manufacturer - Category
Cell Lines

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: One Frozen vial
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close